2009
DOI: 10.1016/j.urolonc.2008.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Post–radical prostatectomy management options for the positive surgical margin: Argument for adjuvant radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…PSM suggests the presence of remnant cancer in the prostate bed, whether viable or not [19, 20]. It is recognized as a strong predictive factor for BCR, and attempting regional control with radiotherapy is known to yield favorable results [21]. Along with PSM, LVI is reported to increase BCR as well in T3 patients.…”
Section: Discussionmentioning
confidence: 99%
“…PSM suggests the presence of remnant cancer in the prostate bed, whether viable or not [19, 20]. It is recognized as a strong predictive factor for BCR, and attempting regional control with radiotherapy is known to yield favorable results [21]. Along with PSM, LVI is reported to increase BCR as well in T3 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Positive surgical margins (PSMs) are associated with a 3.7 times greater risk of prostate cancer recurrence [3] and have significant implications in patients with otherwise organ‐confined disease [4]. Despite the advances in prostate surgery, once a patient with organ‐confined disease has a PSM, his/her prognosis is similar to those with extracapsular extension of prostate carcinoma with or without PSMs [5,6].…”
Section: Introductionmentioning
confidence: 99%
“…The overall results of randomized series, including a series with 385 participants from Germany published only in abstract form thus far, 3 indicate a 20%-50% reduction in risk of prostate-specific antigen (PSA) relapse and disease recurrence, with improved biochemical progression-free survival and local control. On meta-analysis of 1743 patients from the 3 randomized trials, ART resulted in improved biochemical progression-free survival (HR = 0.47, p < 0.001) and deferred requirement for adjuvant therapies (radiation and androgen ablation) with their associated adverse effects.…”
Section: Evidence From Randomized Controlled Trialsmentioning
confidence: 99%